Why the study?
Does captopril reduce blood pressure and alter plasma renin activity in hypertensive patients?
Does captopril reduce blood pressure and alter plasma renin activity in hypertensive patients?
Captopril significantly reduces mean arterial pressure in hypertensive patients, with the magnitude of decrease correlating with plasma renin activity.
Captopril was associated with reduced mean arterial pressure in hypertensives; leaves open causal effects and renin correlation pending randomized trials.
Short-term hypertensive and hormonal effects of captopril were studied in 26 hypertensive patients. Blood pressure (BP) and heart rate were recorded in subjects in the supine position 1 hr before and 3 hr after an oral dose of 1 mg/kg. Urinary, plasma electrolytes, plasma renin activity (PRA), and plasma aldosterone (PA) were determined before and after the test. It was verified, in a preliminary investigation involving 5 patients, that a placebo did not alter the measured parameters. Captopril decreased mean arterial pressure (mean ABP +/- SD) from 128 +/- 2.5 to 108.5 +/- 2.6 mm Hg (p less than 0.001); the maximum decrease was between 30 and 180 min. No changes in heart rate or plasma electrolytes were noted. PRA increased after captopril from 2.29 +/- 0.96 to 3.13 +/- 1.25 and to 4.11 +/- 1.87 at 1 hr and 3 hr (p less than 0.05). There was a correlation between PRA in standing subjects before captopril and decrease in mean ABP (r = 0.59, p less than 0.01). The best correlation was between the decrease in mean ABP and the maximum increase in PRA after captopril (r = 0.69). A good correlation was found between mean ABP and PRA 3 hr after captopril (r = 0.62). Correlation coefficients between decrease in mean ABP and either precaptopril PA or decrease in PA were not significant. In 14 patients, captopril (5.1 +/- 0.61 mg/kg/day) for 4 mo induced the same decrease in mean ABP that was observed during the test. After short- and long-term captopril, mean ABP correlated (r = 0.76, p less than 0.01).
No takes yet. Share an insight, caveat, or question.
Guillevin et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: